Medication info

Linaglipton Empagliflozin 10/5 Milligrams (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›10mgLinagliptin Micronized›5mg
Manufacturer / importer
Cheil Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202502793 · Approved 2025.10.29

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed in patients who tolerate empagliflozin 10 mg/linagliptin 5 mg, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive the same doses they were taking previously. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an eGFR of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Cheil Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary therapy and exercise therapy to help control blood sugar in patients with type 2 diabetes. Empagliflozin and linagliptin work together to effectively lower blood sugar and improve blood sugar control. This supports diabetes management in patients and enhances treatment effects.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed in patients who tolerate empagliflozin 10 mg/linagliptin 5 mg, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive the same doses they were taking previously. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an eGFR of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment is necessary based on age. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication consists of the ingredients empagliflozin and linagliptin, and is primarily used for the treatment of type 2 diabetes. This medication should not be used in patients allergic to empagliflozin or linagliptin, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients currently undergoing kidney dialysis. In patients with impaired kidney function, the effectiveness of this medication may be decreased, hence kidney function should be regularly monitored and administered with caution. Patients with heart failure or a history of pancreatitis also need to be cautious while taking this medication, and if severe abdominal pain, a symptom of pancreatitis, occurs, the medication should be stopped immediately. This medication may cause side effects such as urinary tract infections, genital infections, hypoglycemia, dehydration, and hypotension, thus symptoms should be discussed with a healthcare professional. Particularly, the risk of hypoglycemia may increase if taken in conjunction with insulin or sulfonylureas, hence caution is required. Elderly patients (75 years or older) should be more careful when administering this medication due to a greater risk of fluid loss and hypotension. It is recommended that pregnant or breastfeeding women do not take this medication and consult healthcare professionals if necessary. The safety and efficacy of this medication have not been established in children under 18 years of age, and it is advisable not to use it in this population. In case of overdose, one should immediately visit a hospital for appropriate treatment, and measures such as removing the drug from the gastrointestinal tract may be necessary depending on the clinical condition. During the course of this medication, caution is advised when driving or operating machinery due to the risk of hypoglycemia. Additionally, patients taking this medication should regularly consult with healthcare professionals and monitor blood sugar, kidney function, and for any adverse reactions.

Side effects

Urinary tract infection, vulvovaginitis, vulvitis, balanitis, genital infection, hypersensitivity, angioedema, urticaria, hypoglycemia, thirst, ketoacidosis, cough, constipation, pancreatitis, oral ulcer formation, itching, rash, vesicular dermatosis, rhabdomyolysis, blood volume depletion, increased urination, dysuria, interstitial nephritis, increased amylase, increased lipase, increased hematocrit, increased serum lipids, increased blood creatinine, decreased glomerular filtration rate, upper abdominal pain, enterocolitis, bowel obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuritis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disturbance, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, benign, malignant and unspecified neoplasm, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, abdominal pain, gastrointestinal disorders, irritable bowel syndrome, burning mouth syndrome, colitis, abdominal discomfort, dysphagia, gastric ulcer, gum bleeding, tooth loss, hemorrhoids, lower abdominal pain, diarrhea, vomiting, gastritis, acute pyelonephritis, lichen planus, rhinitis, soft tissue infection, pharyngitis, tsutsugamushi disease, periodontitis, tonsillitis, laryngitis, viral upper respiratory infection, tonsillitis, decreased appetite, hypercholesterolemia, inadequate control of diabetes, malnutrition, hyponatremia, headache, drowsiness, discomfort in the chest, weakness, nosebleed, oropharyngeal pain, voice disturbance, allergic rhinitis, exertional dyspnea, wet cough, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in the blood, increased urine albumin/creatinine ratio, urine white blood cell positive, decreased hemoglobin, increased potassium in the blood, increased creatinine in the blood, increased creatine phosphokinase in the blood, increased ALT, male pattern baldness, hyperhidrosis, hair loss, dermatitis, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, pneumoconiosis, laceration, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, pressure urinary incontinence, hematuria, hearing loss, erectile dysfunction, thyroid goiter, anemia, lymphadenopathy, vulvar pruritus, genital pruritus, obesity, hyponatremia, vitamin D deficiency, dermal cyst, seborrheic dermatitis, atopic dermatitis, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, astigmatism, blurred vision, corneal erosion, macular fibrosis, ocular congestion, pathological myopia, retinal crystals, retinal vein occlusion, retinal detachment with tears, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, age-related dyspnea, wet cough, retained sputum, skin laceration, rib fracture, iliotibial band syndrome, angina, palpitations, Prinzmetal angina, coronary artery disease, tachycardia, arteriosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral artery occlusive disease, anxiety, sleep disorders, hepatitis, otalgia, orthostatic dizziness, dizziness, hypothyroidism, thyroid mass

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it should be kept in a place away from extremes of temperature, ideally between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.